Umbilical Cord Tissue being used to treat Multiple Sclerosis

Translational Biosciences, a subsidiary of Medistem Panama, has received the green light for a phase I/II clinical trial using human umbilical cord-derived mesenchymal stem cells (UC-MSC) for multiple sclerosis from the Comité Nacional de Bioética de la Investigación (CNEI) Institutional Review Board (IRB). Mesenchymal stem cells harvested from donated human umbilical cord tissue after normal,(…)